Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.95 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.95 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.95 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.95 |
| ▸ | CES2 | O00748 | 1/20 | 0.67 |
| ▸ | CES1 | P23141 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | GSK3B | P49841 | 1/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.53 |
| ▸ | NPC1 | O15118 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | PKM | P14618 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.52 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Picolinic Acid SCHEMBL29368665 | 0.98 | — | — | |
| 2-Picolinic Acid SCHEMBL28737810 | 0.98 | LMNA (1.00) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL674837 | 0.98 | LMNA (1.00) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL7457912 | 0.98 | LMNA (1.00) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL36055 | 0.98 | — | — | |
| 2-Picolinic Acid SCHEMBL5203401 | 0.95 | LMNA (0.95) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL15401824 | 0.95 | LMNA (0.95) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL5058097 | 0.95 | LMNA (0.95) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL22835776 | 0.95 | LMNA (0.95) | LMNAL3MBTL1NAPRTP4HTMCES2 | |
| 2-Picolinic Acid SCHEMBL20721125 | 0.95 | LMNA (0.95) | LMNAL3MBTL1NAPRTP4HTMCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119193573-A | Screening method of selenium-enriched saccharomycetes | 安琪酵母股份有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-105848627-A | Lip composition in the form of an inverse emulsion comprising a humectant, and treatment process using the same | 莱雅公司 | 2016-08-10 | — | — | CN | claimed |
| CN-1772737-A | Synthesis process of chronium 2-picolinate | SHANXI COAL CHEM INST (CN) | 2006-05-17 | — | — | CN | claimed |
| CN-119193573-A | Screening method of selenium-enriched saccharomycetes | 安琪酵母股份有限公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-109942600-A | A kind of preparation method of Yi Dushaban | 内蒙古京东药业有限公司 | 2019-06-28 | — | — | CN | disclosed |
| CN-104736136-B | Beauty and make-up is used or medicinal moisturizing ingredient | 巴斯夫美容护理法国公司 | 2019-02-15 | — | — | CN | disclosed |
| CN-108472202-A | Cosmetic composition comprising ceramide and cholesterol | 莱雅公司 | 2018-08-31 | — | — | CN | disclosed |
| CN-108366924-A | Cosmetic composition comprising a specific filler combination and a film-forming polymer to improve long-lasting effect | 莱雅公司 | 2018-08-03 | — | — | CN | disclosed |
| CN-107787221-A | Include the aqueous cosmetic composition of alkylcellulose, at least one nonvolatile oil and resin based on hydrocarbon | 莱雅公司 | 2018-03-09 | — | — | CN | disclosed |
| CN-105008358-B | inhibitors of human immunodeficiency virus replication | 百时美施贵宝公司 | 2017-12-29 | — | — | CN | disclosed |
| CN-107375019-A | AQUEOUS COSMETIC COMPOSITION COMPRISING ALKYLCELLULOSE | 欧莱雅 | 2017-11-24 | — | — | CN | disclosed |
| CN-101099715-B | Cosmetic compositions combining a C-glycoside derivative and an N-acylamino amide derivative | OU LAIYA | 2012-09-05 | — | — | CN | disclosed |
| CN-102223924-A | Photoprotective composition containing an unmodified gelling starch and polyamide particles | OREAL | 2011-10-19 | — | — | CN | disclosed |
| CN-101810543-A | Cosmetic composition and a light stabilizing method thereof | OLIER CHEMISTRY INDUSTRY CO LTD | 2010-08-25 | — | — | CN | disclosed |
| EP-2099796-A1 | AZA-INDOLYL COMPOUNDS AND METHODS OF USE | Genentech, Inc. (US) | 2009-09-16 | — | — | EP | disclosed |
| WO-2008067481-A1 | AZA-INDOLYL COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2008-06-05 | — | — | WO | disclosed |
| CN-101099715-A | Cosmetic compositions combining a C-glycoside derivative and an N-acylamino amide derivative | OREAL (FR) | 2008-01-09 | — | — | CN | disclosed |
| CN-1772737-A | Synthesis process of chronium 2-picolinate | SHANXI COAL CHEM INST (CN) | 2006-05-17 | — | — | CN | disclosed |
| EP-1586578-A2 | Method of removing allyl series protecting group using novel ruthenium complex and method of synthesizing allyl ethers | NAGOYA UNIVERSITY (JP) | 2005-10-19 | — | — | EP | disclosed |
| US-20050203317-A1 | Method of removing allyl series protecting group using novel ruthenium complex and method of synthesizing allyl ethers | NAGOYA UNIVERSITY, A NATIONAL UNIV. CORP. OF JP (JP) | 2005-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050203317-A1 | Method of removing allyl series protecting group using novel ruthenium complex and method of synthesizing allyl ethers | AP2M1, AP3M1, AP2A2 | LMNA 2713/4885L3MBTL1 2694/4885NAPRT 4376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.